Analyst Ratings for Krystal Biotech (KRYS)
KRYS Rating Summary
KRYS Price Target Summary
- Highest: $204.00 (Stifel)
- Lowest: $140.00 (BofA Securities)
- Average: $169.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$169.40 (-0.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$169.40 (-0.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/20/2023 | Goldman Sachs | Andrea Tan | New Coverage | Buy (N/A) |
160.00 (N/A) |
98.34 (169.64) |
72.5% | Details |
| 10/24/2023 | Cantor Fitzgerald | Josh Schimmer | New Coverage | Overweight (N/A) |
160.00 (N/A) |
108.96 (169.64) |
55.69% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
